On Eve Of House Hearing, FDA Makes Its Case For LDT Framework
This article was originally published in The Gray Sheet
Executive Summary
The agency details 20 case studies to support its planned framework for regulating laboratory-developed tests in a report issued the day before a House subcommittee held a hearing on alternative legislative schemes.